These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 76965)

  • 1. Hypertensive response to labetalol in phaeochromocytoma.
    Briggs RS; Birtwell AJ; Pohl JE
    Lancet; 1978 May; 1(8072):1045-6. PubMed ID: 76965
    [No Abstract]   [Full Text] [Related]  

  • 2. Labetalol and phaeochromocytoma.
    Navaratnarajah M; White DC
    Br J Anaesth; 1984 Oct; 56(10):1179. PubMed ID: 6477797
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertensive response to labetalol in phaeochromocytoma.
    Feek CM; Earnshaw PM
    Br Med J; 1980 Aug; 281(6236):387. PubMed ID: 7427286
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypertensive response to labetalol in phaeochromocytoma.
    FitzGerald GA
    Lancet; 1978 Jun; 1(8076):1259. PubMed ID: 78019
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.
    Reach G; Thibonnier M; Chevillard C; Corvol P; Milliez P
    Br Med J; 1980 May; 280(6227):1300-1. PubMed ID: 7388518
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical effects of labetalol in 21 patients with phaeochromocytoma (author's transl)].
    Yoshinaga K; Arakawa K; Ikeda M; Ebihara T; Oe N
    Horumon To Rinsho; 1981 Apr; 29(4):515-22. PubMed ID: 7296922
    [No Abstract]   [Full Text] [Related]  

  • 7. Erroneous diagnosis of phaeochromocytoma in hypertensive patient on labetalol.
    Bouloux PM; Featherstone RM; Clement-Jones V; Rees LH; Goligher JE
    J R Soc Med; 1985 Jul; 78(7):588-9. PubMed ID: 4009571
    [No Abstract]   [Full Text] [Related]  

  • 8. [Malignant pheochromocytoma: blood pressure controlled by labetalol].
    Sugano O; Hirano J; Hirano K; Kubota Y; Numasawa K; Kawamura S
    Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):523-7. PubMed ID: 6471663
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypertensive response to labetalol in pheochromocytoma].
    Enoki N; Satoh Z; Ogata A; Yukioka H; Nishimura K; Fujimori M
    Masui; 1984 Sep; 33(9):1008-11. PubMed ID: 6512967
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical effects of labetalol on pheochromocytoma].
    Yoshinaga K; Arakawa K; Ando H; Iai F; Ikeda M
    Horumon To Rinsho; 1983 Feb; 31(2):183-92. PubMed ID: 6340865
    [No Abstract]   [Full Text] [Related]  

  • 11. Labetalol in the preoperative management of phaeochromocytoma.
    Russell WJ; Kaines AH; Hooper MJ; Frewin DB
    Anaesth Intensive Care; 1982 May; 10(2):160-3. PubMed ID: 6125109
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pheochromocytoma treated with combined alpha-beta blockader].
    Nyberg G; Waldenström J; Vedin A
    Lakartidningen; 1979 Jun; 76(23):2248-50. PubMed ID: 459631
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.
    Rosei EA; Brown JJ; Lever AF; Robertson AS; Robertson JI; Trust PM
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):809-15. PubMed ID: 990158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
    Rosei EA; Fraser R; Morton JJ; Brown JJ; Lever AF; Robertson JI; Trust PM
    Am Heart J; 1977 Jan; 93(1):124-5. PubMed ID: 12654
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid cyclic fluctuations of blood pressure associated with treatment of pheochromocytoma by labetalol.
    Kojima S; Natsume T; Ito K; Ikeda M
    Jpn Heart J; 1985 Nov; 26(6):1039-41. PubMed ID: 3831407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of blood pressure control by a new combined alpha- and beta-blocking agent (amosulalol) in a patient with pheochromocytoma.
    Yamaguchi T; Irisawa C; Watanabe H; Kawamura S; Nakada T
    Int Urol Nephrol; 1991; 23(3):209-14. PubMed ID: 1889965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Falsely high urinary catecholamines induced by labetalol.
    Kobayashi K; Miura Y; Tomioka H; Sakuma H; Adachi M; Abe K; Yoshinaga K
    Tohoku J Exp Med; 1979 Jan; 127(1):63-9. PubMed ID: 760251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labetalol in the treatment of a patient with phaechromocytoma: a case report.
    Bailey RR
    Br J Clin Pharmacol; 1979; 8(Suppl 2):141S-142S. PubMed ID: 526394
    [No Abstract]   [Full Text] [Related]  

  • 20. Labetalol: a review of its pharmacology and therapeutic use in hypertension.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Apr; 15(4):251-70. PubMed ID: 25757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.